Efficacy of eicosapentaenoic acid on the prevention of preterm birth in women with cervical shortening
Not Applicable
Completed
- Conditions
- threatened preterm delivery
- Registration Number
- JPRN-UMIN000027997
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 99
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who was transferred from other hospitals 2)Patients with a past history of conization 3)Patients who underwent cervical cerclage in current pregnancy 4)Premature rupture of the membrane 5)fetal anomalies detected by ultrasonography 6)Prolapsed fetal membranes 7)Chorioamnionitis 8)White blood cell count > or =15,000/mm3 or CRP > or =1.0mg/dl 9)Placenta previa 10)Multiple pregnancy 11)Painful degeneration of myomas during pregnancy 12)Uterine malformations 13)Previous medication of eicosapentaenoic acid 14)Medication with low-dose aspirin 15)Patients judged to be ineligible by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preterm birth
- Secondary Outcome Measures
Name Time Method 1)gestational age at delivery 2)Birth weight, Apgar score, pH of umbilical arterial blood 3)Cervical length 4)Maternal adverse event 5)Neonatal adverse event 6)Occurrence of adverse events toward neonates 7)Duration of hospital stays 8)Duration of use of a tocolytic agent (ritodrine hydrochloride preparation, magnesium sulfate preparation) 9)Nutrient intakes